Sep 05, 2025 12:35
PTCT - PTC Therapeutics, Inc.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
67.0 3.03 (4.52%) | --- | --- | 1.24 (1.8%) | 0.0 (0.0%) | 2.74 (4.16%) | 1.28 (1.86%) | 1.28 (1.86%) |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
Earnings & Ratios
- Basic EPS:
- -0.83
- Diluted EPS:
- -0.83
- Basic P/E:
- -84.3735
- Diluted P/E:
- -84.3735
- RSI(14) 1m:
- 100.0
- VWAP:
- 70.03
- RVol:
- 1.0177
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Jul 17, 2025 05:00
Jun 02, 2025 17:55
Jun 02, 2025 17:52
May 29, 2025 14:56
May 26, 2025 17:00
Aug 03, 2024 19:41
Jul 09, 2024 18:01
Jul 01, 2024 12:00
Jun 24, 2024 08:44